Louise Roberts

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 562 citations · Full text

Medicine, Oncology, Pharmacology +11

Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients

Ryan J. Sullivan, Omid Hamid, René González et al. · Nature Medicine · 2019 · 236 citations

Medicine, Oncology, Pharmacotherapy +11

Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth

Bérengère Aubert-Broche, Vladimir Fonov, Sridar Narayanan et al. · Neurology · 2014 · 146 citations · Full text

Medicine, Neurology, Neuroscience +12

The consequences of being labelled ‘looked‐after’: Exploring the educational experiences of looked‐after children and young people in Wales

Dawn Mannay, Rhiannon Evans, Eleanor Staples et al. · British Educational Research Journal · 2017 · 93 citations · Full text

Public Affairs, Education Policy, Child Development +9

Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons

Louise Roberts, MacDonald J. Christie, Mark Connor · British Journal of Pharmacology · 2002 · 79 citations · Full text

Medicine, Neuroscience, Pharmacology +17